riteaid is a company based out of 7189 henry clay blvd, liverpool, new york, united states.
Company profile
Ticker
RADCQ
Exchange
Website
CEO
Heyward Donigan
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
1515 West State Street Boise, Idaho, LLC • 1740 Associates, LLC • 4042 Warrensville Center Road—Warrensville Ohio, Inc. • 5277 Associates, Inc. • 5600 Superior Properties, Inc. • Advance Benefits, LLC • Apex Drug Stores, Inc. • Ascend Health Technology, LLC • Broadview and Wallings—Broadview Heights Ohio, Inc. • Design Rx, LLC ...
IRS number
231614034
RADCQ stock data
Latest filings (excl ownership)
8-K
Completion of Acquisition or Disposition of Assets
6 Feb 24
NT 10-Q
Notice of late quarterly filing
12 Jan 24
8-K
Entry into a Material Definitive Agreement
27 Dec 23
8-K
Entry into a Material Definitive Agreement
1 Nov 23
25-NSE
Exchange delisting
31 Oct 23
8-K
Rite Aid Corporation Appoints Jeffrey S. Stein Chief Executive Officer
19 Oct 23
10-Q
2024 Q2
Quarterly report
17 Oct 23
8-K/A
Reaches Agreement in Principle with Key Creditors on the Terms of Financial Restructuring Plan
16 Oct 23
8-K
Reaches Agreement in Principle with Key Creditors on the Terms of Financial Restructuring Plan
16 Oct 23
NT 10-Q
Notice of late quarterly filing
12 Oct 23
Transcripts
RADCQ
Earnings call transcript
2023 Q4
20 Apr 23
RADCQ
Earnings call transcript
2023 Q3
21 Dec 22
RADCQ
Earnings call transcript
2023 Q2
29 Sep 22
RADCQ
Earnings call transcript
2023 Q1
23 Jun 22
RADCQ
Earnings call transcript
2022 Q4
14 Apr 22
RADCQ
Earnings call transcript
2022 Q3
21 Dec 21
RADCQ
Earnings call transcript
2022 Q2
23 Sep 21
RADCQ
Earnings call transcript
2022 Q1
24 Jun 21
RADCQ
Earnings call transcript
2021 Q4
15 Apr 21
RADCQ
Earnings call transcript
2021 Q4
15 Apr 21
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Nov 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Mar 23 | Feb 22 | Feb 21 | Feb 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 92.93 mm | 92.93 mm | 92.93 mm | 92.93 mm | 92.93 mm | 92.93 mm |
Cash burn (monthly) | 14.20 mm | (no burn) | 339.23 mm | 137.78 mm | 146.87 mm | 79.72 mm |
Cash used (since last report) | 107.60 mm | n/a | 2.57 bn | 1.04 bn | 1.11 bn | 604.04 mm |
Cash remaining | -14.67 mm | n/a | -2.48 bn | -951.00 mm | -1.02 bn | -511.12 mm |
Runway (months of cash) | -1.0 | n/a | -7.3 | -6.9 | -6.9 | -6.4 |
Institutional ownership, Q3 2023
29.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 99 |
Opened positions | 17 |
Closed positions | 28 |
Increased positions | 17 |
Reduced positions | 24 |
13F shares | Current |
---|---|
Total value | 6.82 bn |
Total shares | 16.60 mm |
Total puts | 8.83 mm |
Total calls | 2.63 mm |
Total put/call ratio | 3.4 |
Largest owners | Shares | Value |
---|---|---|
Charles Schwab Investment Management | 5.00 mm | $2.24 bn |
Vanguard | 2.90 mm | $1.30 bn |
GMT Capital | 1.48 mm | $663.98 mm |
BCS Barclays | 1.14 mm | $508.00 k |
BLK Blackrock | 1.02 mm | $458.23 mm |
Renaissance Technologies | 722.60 k | $330.68 mm |
Susquehanna International | 640.39 k | $286.90 mm |
Geode Capital Management | 540.04 k | $242.00 mm |
Silver Point Capital | 500.00 k | $224.00 mm |
STT State Street | 325.69 k | $145.91 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Jul 23 | Kazmaier Jessica | Common Stock | Payment of exercise | Dispose F | No | No | 1.58 | 6,934 | 10.96 k | 89,794 |
27 Jul 23 | Schroeder Matt | Common Stock | Payment of exercise | Dispose F | No | No | 1.58 | 17,349 | 27.41 k | 195,781 |
27 Jul 23 | Mennen Justin L. | Common Stock | Payment of exercise | Dispose F | No | No | 1.58 | 4,968 | 7.85 k | 136,342 |
7 Jul 23 | Steven Bixler | Common Stock | Payment of exercise | Dispose F | No | No | 1.64 | 147 | 241.08 | 3,540 |
7 Jul 23 | Steven Bixler | Common Stock | Payment of exercise | Dispose F | No | No | 1.64 | 208 | 341.12 | 3,687 |
Press releases
Rite Aid Becomes Copia's First Retail Pharmacy Partner to Help Combat Food Waste and Support Communities
12 Mar 24
Rite Aid Enters into Agreement to Divest Majority of Health Dialog Assets
6 Mar 24
Rite Aid and Bartell Drugs Announce Additional Dose of Updated COVID-19 Vaccine Available for Customers Ages 65 and Older
5 Mar 24
Rite Aid Unveils New 'It Means More' Ad Spot, Showcasing Unwavering Commitment to Serving and Supporting Its Customers
22 Feb 24
Rite Aid Completes Sale of Elixir Solutions to MedImpact
1 Feb 24